|
Market Closed -
Hong Kong S.E.
12:08:52 06/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 11.09 HKD | -0.72% |
|
+9.37% | -7.35% |
| 11-06 | Simcere Pharmaceutical's Rheumatoid Arthritis Drug Application Accepted in China | MT |
| 11-02 | Simcere Pharma to Get Expanded Commercialization Rights for Zemprocitinib in China | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Specialty & Advanced Pharmaceuticals | -0.72% | +9.37% | -7.35% | -14.10% | +42.54% | 3.63B |  | | |
- Stock Market
- Stocks
- 2096 Stock
- Charts Simcere Pharmaceutical Group Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
